Addition of bortezomib to high-dose cyclophosphamide therapy as a conditioning regimen for autologous peripheral blood stem cell harvest leads to an increased yield of hematopoietic stem cells

Peripheral blood stem cell harvest (PBSCH) is a crucial procedure for autologous stem cell transplantation in patients with multiple myeloma. We herein report a retrospective study to verify the usefulness of bortezomib and high-dose cyclophosphamide therapy (Bor-HDCY) as a conditioning regimen for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohno, Sayaka, Hayashi, Kiyohito, Shimizu, Ryo, Ishii, Akihiro, Tanaka, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635030/
https://www.ncbi.nlm.nih.gov/pubmed/35979578
http://dx.doi.org/10.3960/jslrt.22013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635030/
https://www.ncbi.nlm.nih.gov/pubmed/35979578
http://dx.doi.org/10.3960/jslrt.22013

Ejemplares similares